Motion Acquisition Corp.: directors' dealings · United States · SEC (Form 4)

About Motion Acquisition Corp.

Motion Acquisition Corp. was a special purpose acquisition company (SPAC) created to pursue a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating businesses. The company was organized under Delaware law, based in New York, United States, and its IPO documents list a business address at 405 Lexington Avenue, New York, NY. Its units were listed on the Nasdaq Capital Market under the ticker MOTNU, and later the common stock and warrants were expected to trade as MOTN and MOTNW once separated. The IPO closed in October 2020 and raised gross proceeds of $115 million. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1822359/000121390020031673/0001213900-20-031673-index.htm)) From a strategic perspective, Motion was backed by a management team described as seasoned executives with experience in transportation software and technology. At launch, the SPAC said it would initially focus on target businesses in connected vehicle industries globally, including companies providing transportation software, cloud solutions for fleet management, freight and logistics, and mobile asset management applications. That positioning gave Motion a niche technology-and-mobility angle rather than a broad generalist SPAC mandate. ([nasdaq.com](https://www.nasdaq.com/press-release/motion-acquisition-corp.-announces-closing-of-%24115000000-initial-public-offering-2020)) The key corporate event in Motion’s history was its business combination with Ambulnz, Inc., doing business as DocGo, announced in March 2021 and approved by shareholders in November 2021. On November 5, 2021, the transaction closed, Motion changed its name to DocGo, Inc., and the listing moved to Nasdaq under the ticker DCGO. For anyone analyzing SEC Form 4 insider transactions, this is an important distinction: insider activity after the closing relates to the operating company DocGo, while Motion Acquisition Corp. effectively ceased to exist as a standalone SPAC. ([nasdaq.com](https://www.nasdaq.com/press-release/motion-acquisition-corp.-and-docgo-announce-shareholder-approval-of-business)) The target business, DocGo, was founded in 2015 and operated a digital-first medical mobility and mobile health platform. Its services included last-mile telehealth support, mobile testing, vaccinations, bloodwork, IV hydration, wound care, mobile imaging, and EKGs. DocGo served hospitals, insurers, municipalities, and large commercial customers, and at the time of the merger it reported operations across 23 U.S. states and in the United Kingdom. The company emphasized proprietary technology, real-time vehicle tracking, estimated arrival times, and an integrated field workforce. ([nasdaq.com](https://www.nasdaq.com/press-release/ambulnz-dba-docgo-a-leading-provider-of-last-mile-telehealth-and-integrated-medical)) In competitive terms, Motion’s appeal lay in its ability to deliver a public-market pathway to an asset with a scalable healthcare logistics platform and recurring customer relationships. The merger materials highlighted a technology-enabled, capex-light model and a sizeable addressable market for mobile health services. However, Motion itself was not an operating business with products or services of its own; its investment relevance was tied to the quality of the business combination and the subsequent public-market performance of DocGo. ([nasdaq.com](https://www.nasdaq.com/press-release/ambulnz-dba-docgo-a-leading-provider-of-last-mile-telehealth-and-integrated-medical)) For United States and Nasdaq investors, Motion Acquisition Corp. is therefore best understood as a historical SPAC shell that transitioned into DocGo. Its most important recent corporate milestone was the completion of that merger, rather than ongoing standalone operations. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1822359/000121390021065504/fs12021a1_docgo.htm?utm_source=openai))